Learn about the current medication options for managing type 2 diabetes and chronic kidney disease, including SGLT2 ...

"As of now, semaglutide is FDA-indicated for slowing chronic kidney disease progression, [but] our results suggest that ...

Although teplizumab doesn’t work for everyone and how much it delays progression varies, it has inspired new directions in ...

An unusual way to deliver drugs gives new meaning to the term “Jell-O shot.” Injected into rats, a water-based gel mixed with the key ingredients in Ozempic or Mounjaro offered long-lasting diabetes ...

A UC San Francisco analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction of the patients who are recommended to take them based on new ...

New research suggests that diabetes and weight-loss drugs known as GLP-1 receptor agonists may also help treat alcohol and ...

A well-established diabetes drug alleviated brain inflammation in a female mouse model of multiple sclerosis, suggesting the ...

A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction of the patients who are recommended to take them based on new guidelines.

Excess body weight can raise the risk of certain cancers, leading researchers to wonder whether blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in cancer prevention. Now, a study ...

Nearly 17 million young Americans could be eligible for GLP-1RAs—a class of medications used to treat type 2 diabetes and obesity—including Ozempic and Wegovy. This is based on estimations from Yale ...

Eli Lilly (LLY) stock is in focus as the company's oral weight loss candidate orforglipron succeeds in two Phase 3 trials for ...